News

Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, ...
Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...
Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...
While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that ...
The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...
Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...
Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...
Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...
AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...
For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...
AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...
The BPLS’ mission is to bridge the ethnic diversity gap in the life sciences industry. It supports and empowers black and ...